Techniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancer

We first discuss several key technical issues associated with quantitative dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), and then provide examples of DCE-MRI in oncology. In particular, we examine the importance of both active and passive delivery of the contrast agent to the tissue under investigation, and repeatability/reproducibility in DCE-MRI studies. We then discuss examples of how DCE-MRI can assist in assessing and predicting therapeutic response in the neoadjuvant setting.

[1]  Gregory S Karczmar,et al.  Estimating the arterial input function using two reference tissues in dynamic contrast‐enhanced MRI studies: Fundamental concepts and simulations , 2004, Magnetic resonance in medicine.

[2]  Thomas E Yankeelov,et al.  A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer , 2011, Physics in medicine and biology.

[3]  Thomas E Yankeelov,et al.  Incorporating contrast agent diffusion into the analysis of DCE‐MRI data , 2007, Magnetic resonance in medicine.

[4]  J. Heverhagen,et al.  Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging. , 2008, Radiology.

[5]  Qing Ji,et al.  Dynamic contrast‐enhanced magnetic resonance imaging as a prognostic factor in predicting event‐free and overall survival in pediatric patients with osteosarcoma , 2012, Cancer.

[6]  Thomas E Yankeelov,et al.  A diffusion-compensated model for the analysis of DCE-MRI data: theory, simulations and experimental results , 2013, Physics in medicine and biology.

[7]  John A Butman,et al.  Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. , 2007, Neoplasia.

[8]  A. Jackson,et al.  Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. , 2003, The British journal of radiology.

[9]  Geoffrey J M Parker,et al.  Comparison of model‐based arterial input functions for dynamic contrast‐enhanced MRI in tumor bearing rats , 2009, Magnetic resonance in medicine.

[10]  J. Gore,et al.  A quantitative comparison of the influence of individual versus population‐derived vascular input functions on dynamic contrast enhanced‐MRI in small animals , 2012, Magnetic resonance in medicine.

[11]  J. Gore,et al.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.

[12]  Xia Li,et al.  DCE‐MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings , 2014, Magnetic resonance in medicine.

[13]  Thomas E Yankeelov,et al.  Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. , 2007, Current medical imaging reviews.

[14]  D. D. Billheimer,et al.  Repeatability of a reference region model for analysis of murine DCE‐MRI data at 7T , 2006, Journal of magnetic resonance imaging : JMRI.

[15]  Thomas E Yankeelov,et al.  Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer , 2013, Magnetic resonance in medicine.

[16]  G. Weinstein,et al.  Prediction of Response to Chemoradiation Therapy in Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging , 2010, American Journal of Neuroradiology.

[17]  M. Haider,et al.  A comparison of dynamic contrast‐enhanced CT and MR imaging‐derived measurements in patients with cervical cancer , 2013, Clinical physiology and functional imaging.

[18]  A. Padhani,et al.  Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.

[19]  Piotr Kozlowski,et al.  Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. , 2010, Academic radiology.

[20]  Carmel Hayes,et al.  Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. , 2006, Radiology.

[21]  G S Karczmar,et al.  A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissues , 1998, Journal of magnetic resonance imaging : JMRI.

[22]  A. Jackson,et al.  Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[23]  L. Esserman,et al.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. , 2012, Radiology.